Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma (vol 14, pg 561, 2019)

被引：0
|
作者：
Plotkin, S. R.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
10.1200/JCO.20.00060
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：656 / 656
页数：1
相关论文
共 50 条
  • [1] Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
    O'Connor, Owen A.
    Ozcan, Muhit
    Jacobsen, Eric D.
    Roncero, Josep M.
    Trotman, Judith
    Demeter, Judit
    Masszi, Tamas
    Pereira, Juliana
    Ramchandren, Radhakrishnan
    Beaven, Anne
    Caballero, Dolores
    Horwitz, Steven M.
    Lennard, Anne
    Turgut, Mehmet
    Hamerschlak, Nelson
    d'Amore, Francesco A.
    Foss, Francine
    Kim, Won-Seog
    Leonard, John P.
    Zinzani, Pier Luigi
    Chiattone, Carlos S.
    Hsi, Eric D.
    Truemper, Lorenz
    Liu, Hua
    Sheldon-Waniga, Emily
    Ullmann, Claudio Dansky
    Venkatakrishnan, Karthik
    Leonard, E. Jane
    Shustov, Andrei R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08) : 613 - +
  • [2] Phase III study of investigational MLN8237 (alisertib) versus investigator's choice in patients (pts) with relapsed/refractory (rel/ref) peripheral T-cell lymphoma (PTCL).
    O'Connor, Owen
    Leonard, E. Jane
    Benaim, Ely
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] First Multicenter, Randomized Phase 3 Study in Patients (Pts) With Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (LUMIERE trial; NCT01482962)
    Chen, Robert W.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (02) : 12 - 13
  • [4] Phase III study of patients with relapsed, refractory mantle cell lymphoma treated with temsirolimus compared with investigator's choice therapy
    Hess, G.
    Romaguera, J. E.
    Verhoef, G.
    Herbrecht, R.
    Crump, M.
    Strahs, A.
    Clancy, J.
    Hewes, B.
    Coiffier, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] First Multicenter, Randomized Phase 3 Study in Patients (Pts) with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (Lumiere trial; NCT01482962)
    O'Connor, Owen A.
    Ozcan, Muhit
    Jacobsen, Eric D.
    Vidal, Josep Maria Roncero
    Trotman, Judith
    Demeter, Judit
    Masszi, Tamas
    Pereira, Juliana
    Ramchandren, Radhakrishnan
    d'Amore, Francesco A.
    Foss, Francine
    Kim, Won-Seog
    Leonard, John P.
    Chiattone, Carlos Sergio
    Zinzani, Pier Luigi
    Liu, Hua
    Jung, JungAh
    Zhou, Xiaofei
    Leonard, E. Jane
    Ullmann, Claudio Dansky
    Shustov, Andrei R.
    BLOOD, 2015, 126 (23)
  • [6] A Phase II Study of Nivolumab in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
    Bennani, N. Nora
    Pederson, Levi D.
    Atherton, Pamela
    Micallef, Ivana
    Colgan, Joseph P.
    Thanarajasingam, Gita
    Nowakowski, Grzegorz
    Witzig, Thomas E.
    Feldman, Andrew L.
    Ansell, Stephen M.
    BLOOD, 2019, 134
  • [7] A Phase Ib Study of Linperlisib in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
    Jin, Jie
    Cen, Hong
    Zhou, Keshu
    Xu, Xiaohong
    Li, Fei
    Yang, Haiyan
    Li, Zhiming
    Bao, Hanying
    Xu, Zusheng
    Qiu, Lugui
    Shu, Yang
    Li, Fei
    Wang, Zhen
    BLOOD, 2021, 138
  • [8] A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma
    Jin, Jie
    Cen, Hong
    Zhou, Keshu
    Xu, Xiaohong
    Li, Fei
    Wu, Tao
    Yang, Haiyan
    Wang, Zhen
    Li, Zhiming
    Huang, Wenyang
    Bao, Hanying
    Xu, Zusheng
    Qiu, Lugui
    CLINICAL CANCER RESEARCH, 2024, 30 (20) : 4593 - 4600
  • [9] Analysis of Patients with Common Peripheral T-Cell Lymphoma Subtypes From a Phase 2 Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma
    Coiffier, Bertrand
    Pro, Barbara
    Prince, H. Miles
    Foss, Francine M.
    Sokol, Lubomir
    Greenwood, Matthew
    Caballero, Dolores
    Borchmann, Peter
    Morschhauser, Franck
    Wilhelm, Martin
    Pinter-Brown, Lauren
    Padmanabhan, Swaminathan
    Shustov, Andrei R.
    Nichols, Jean
    Carroll, Susan
    Balser, John
    Horwitz, Steven M.
    BLOOD, 2011, 118 (21) : 272 - 272
  • [10] Pooled analysis of pralatrexate single-agent studies in patients with relapsed/refractory peripheral T-cell lymphoma
    O'Connor, Owen A.
    Ko, Bor-Sheng
    Wang, Ming-Chung
    Maruyama, Dai
    Song, Yuqin
    Yeoh, Ee-Min
    Manamley, Nick
    Tobinai, Kensei
    BLOOD ADVANCES, 2024, 8 (11) : 2601 - 2611
12345